Biosimilar Diplomacy By Other Means: GPhA CEO Calls Out Amgen Guest

During speech to the group’s annual meeting, GPhA President Ralph Neas says he is disappointed that Amgen, which is among the firms attending the gathering, is pushing biosimilar substitution restrictions in state legislatures.